Our success speaks for itself: discover our numerous awards.
We’re proud to be one of the 20 leading pharmaceutical companies in the world –
and a global leader in animal health and biopharmaceuticals . Since our foundation in
1885, we’ve been driven by the desire to serve mankind by improving human and animal health. Working across three business areas –
human pharmaceuticals, animal health and biopharmaceuticals – we partner globally
to provide sustainable solutions for our patients now and for the future.
Human pharmaceuticals, our biggest business, accounted for 72% of our total net sales in 2018. As a leading pharmaceutical company, trusted by healthcare professionals and their patients,
we’re committed to providing prescription medicines and healthcare solutions which
address many of the world’s greatest health challenges. Learn more here.
We care about the health of animals. That’s why more than 10,000 employees worldwide work every day to develop innovative and improved vaccines, parasiticides and pharmaceuticals that protect animals against disease and pain.
In 2018, our animal health
business represented 23% of our total net sales (2016: 9% of total net sales).
Boehringer Ingelheim BioXcellence™ is one of the world’s leading providers of tailor-made contract development and biopharmaceuticals manufacturing, offering the entire production technology chain from DNA to fill-finish operations. During our 35 years in the field of biotechnology, we’ve helped our customers bring 27 molecules to the market, earning us a reputation as one of the most experienced and reliable contract manufacturing organizations in the world. Learn more here.